Services search (in the department)
| Illness | Number of cases |
|---|---|
| Lymphoid leukaemia - Acute lymphoblastic leukemia not having achieved remission (C91.00) | 294 |
| Malignant neoplasm of peripheral nerves and autonomic nervous system - Malignant neoplasm of overlapping sites of peripheral nerves and autonomic nervous system (C47.8) | 61 |
| Malignant neoplasm of liver and intrahepatic bile ducts - Hepatoblastoma (C22.2) | 35 |
| Malignant neoplasm of bone and articular cartilage of limbs (C40.2) | 29 |
| Malignant neoplasm of kidney except renal pelvis (C64) | 22 |
| Monocytic leukaemia - Acute monoblastic/monocytic leukemia not having achieved remission (C93.00) | 20 |
| Other leukaemias of specified cell type - Acute megakaryoblastic leukemia not having achieved remission (C94.20) | 19 |
| Myeloid leukaemia - Acute myeloblastic leukemia not having achieved remission (C92.00) | 15 |
| Malignant neoplasm of ovary (C56) | 13 |
| Agranulocytosis secondary to cancer chemotherapy (D70.13) | 12 |
| Treatment | Number |
|---|---|
| (9-985.0) | 349 |
| Cancer treatment for one or more days with chemotherapy drugs administered into a vein or beneath the skin (8-542.11) | 235 |
| (9-984.7) | 164 |
| (9-984.b) | 162 |
| (9-984.8) | 146 |
| Treatment by injecting a medicine into an organ or tissue, or removal of excess fluid (effusion) e.g. from the joints (8-020.x) | 136 |
| Transfusion of blood, red blood cells or platelets from a donor to a recipient (8-800.c0) | 107 |
| (1-999.3) | 92 |
| Instillation into a body cavity and locally restricted treatment with chemotherapy drugs or agents that influence the immune system (8-541.0) | 80 |
| Treatment by the targeted insertion of a needle into the brain, spinal cord or the eye with subsequent administration or removal of substances, e.g. fluid (8-151.4) | 75 |
| No. | Explanation |
|---|---|
| CQ05 | |
| CQ02 |
| Number | Group |
|---|---|
| 91 | Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training* |
| 8 | Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence |
| 8 | Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations |
| Job | Explanation |
|---|---|
| Doctoral supervision | |
| Lectureships / teaching posts at universities of applied sciences | |
| Project-related cooperation with colleges and universities | |
| Lectureships / teaching posts at colleges and universities | |
| Student training (clinical traineeship / internship year) | |
| Participation in multi-centre phase III/IV studies | |
| Participation in multi-centre Phase I/II studies | |
| Editors of scientific journals/textbooks |
| No. | Training in other healing professions | Comment |
|---|---|---|
| HB01 | Nurse and health care worker (m/f) | |
| HB07 | Surgical technical assistant (m/f) | |
| HB12 | Medical technical laboratory assistant (MTLA) (m/f) | |
| HB10 | Midwife (m/f) | |
| HB02 | Health and paediatric nurse (m/f) | |
| HB20 | Nursing professional B. Sc. | |
| HB19 | Nursing professionals |
Andrea Halberschmidt
Qualitätsmanagerin
Phone:
0911
-3340-5058
Mail:
ed.oenokaid@CHK.tnemeganamedrewhcseB
Andrea Halberschmidt
Qualitätsmanagerin
Phone:
0911
-3340-5058
Mail:
ed.oenokaid@tdimhcsreblah.aerdna
Prof. Dr. Michael Kranzfelder
Chefarzt Allgemein- und Viszeralchirurgie
Phone:
0911
-3340-2600
Mail:
ed.oenokaid@redlefznark.leahciM
Mag. pharm. Wilhelm Bouhon
externer Apotheker , Kooperationspartner Mohren Apotheke
Phone:
0911
-206-330
Mail:
gro.ekehtopA-nerhoM@nohuoB.mlehliW